The Federal Trade Commission (FTC) is suing Uber for allegedly deceptive subscription practices related to its Uber One service. The FTC claims Uber enrolled users without consent and made cancellations excessively difficult, requiring numerous steps. Uber denies these allegations, stating that cancellations are now easily performed within the app. This lawsuit marks the FTC’s first against a major US tech company since the start of President Trump’s second term. The case highlights ongoing scrutiny of tech companies’ billing and consumer protection practices.
Read More
CVS Health, UnitedHealth Group, and Cigna filed a lawsuit against the FTC, arguing the agency’s administrative court proceedings regarding insulin pricing violate their Fifth Amendment due process rights. The companies contend the FTC’s claims, alleging a “perverse” rebate system inflates insulin costs, should be litigated in federal court, not the agency’s internal process. They argue the FTC’s structure lacks democratic accountability, deeming the process fundamentally unfair. The FTC responded that the companies’ constitutional challenge is a distraction from accusations of harming patients through inflated insulin prices. This action follows earlier recusal requests based on alleged commissioner bias.
Read More
John Q. Hosedrinker